Return On Equity in % of Lipocine Inc. from Q2 2013 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lipocine Inc. quarterly/annual Return On Equity history and change rate from Q2 2013 to Q3 2025.
  • Lipocine Inc. Return On Equity for the quarter ending 30 Sep 2025 was -30 %, a 59.9% decline year-over-year.
  • Lipocine Inc. annual Return On Equity for 2024 was 0 %.
  • Lipocine Inc. annual Return On Equity for 2023 was -63 %, a 129% decline from 2022.
  • Lipocine Inc. annual Return On Equity for 2022 was -27 %, a 1606% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Lipocine Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -30 -11 -59.9% 01 Jul 2025 30 Sep 2025
Q2 2025 -23 +15 +38.9% 01 Apr 2025 30 Jun 2025
Q1 2025 -26 +11 +29.1% 01 Jan 2025 31 Mar 2025
Q4 2024 0 +63 01 Oct 2024 31 Dec 2024
Q3 2024 -19 +36 +65.1% 01 Jul 2024 30 Sep 2024
Q2 2024 -38 -3 -7% 01 Apr 2024 30 Jun 2024
Q1 2024 -37 -7 -22.5% 01 Jan 2024 31 Mar 2024
Q4 2023 -63 -36 -1.3% 01 Oct 2023 31 Dec 2023
Q3 2023 -54 -65 -6.6% 01 Jul 2023 30 Sep 2023
Q2 2023 -36 -45 -5.2% 01 Apr 2023 30 Jun 2023
Q1 2023 -30 -29 -14.9% 01 Jan 2023 31 Mar 2023
Q4 2022 -27 -26 -16.1% 01 Oct 2022 31 Dec 2022
Q3 2022 9 +66 01 Jul 2022 30 Sep 2022
Q2 2022 8 +79 01 Apr 2022 30 Jun 2022
Q1 2022 -1 +85 +97.8% 01 Jan 2022 31 Mar 2022
Q4 2021 -1 +168 +99% 01 Oct 2021 31 Dec 2021
Q3 2021 -56 +139 +71.2% 01 Jul 2021 30 Sep 2021
Q2 2021 -70 +151 +68.2% 01 Apr 2021 30 Jun 2021
Q1 2021 -87 +119 +57.8% 01 Jan 2021 31 Mar 2021
Q4 2020 -169 -26 -17.9% 01 Oct 2020 31 Dec 2020
Q3 2020 -195 -64 -48.5% 01 Jul 2020 30 Sep 2020
Q2 2020 -221 -108 -95.4% 01 Apr 2020 30 Jun 2020
Q1 2020 -206 -104 -1% 01 Jan 2020 31 Mar 2020
Q4 2019 -143 -54 -59.5% 01 Oct 2019 31 Dec 2019
Q3 2019 -131 -42 -46.5% 01 Jul 2019 30 Sep 2019
Q2 2019 -113 -26 -29.6% 01 Apr 2019 30 Jun 2019
Q1 2019 -102 -13 -14.6% 01 Jan 2019 31 Mar 2019
Q4 2018 -90 +0 +0.38% 01 Oct 2018 31 Dec 2018
Q3 2018 -89 -15 -20.4% 01 Jul 2018 30 Sep 2018
Q2 2018 -87 -21 -32.4% 01 Apr 2018 30 Jun 2018
Q1 2018 -89 -28 -45.2% 01 Jan 2018 31 Mar 2018
Q4 2017 -90 -28 -43.7% 01 Oct 2017 31 Dec 2017
Q3 2017 -74 -14 -23.4% 01 Jul 2017 30 Sep 2017
Q2 2017 -65 -5 -7.3% 01 Apr 2017 30 Jun 2017
Q1 2017 -61 -11 -21.4% 01 Jan 2017 31 Mar 2017
Q4 2016 -62 -19 -41.8% 01 Oct 2016 31 Dec 2016
Q3 2016 -60 -13 -27.4% 01 Jul 2016 30 Sep 2016
Q2 2016 -61 -15 -32.4% 01 Apr 2016 30 Jun 2016
Q1 2016 -50 +13 +20.3% 01 Jan 2016 31 Mar 2016
Q4 2015 -44 +18 +28.8% 01 Oct 2015 31 Dec 2015
Q3 2015 -47 +8 +14.6% 01 Jul 2015 30 Sep 2015
Q2 2015 -46 +6 +10.7% 01 Apr 2015 30 Jun 2015
Q1 2015 -63 -15 -32.3% 01 Jan 2015 31 Mar 2015
Q4 2014 -62 -10 -18.2% 01 Oct 2014 31 Dec 2014
Q3 2014 -55 -44 -3.8% 01 Jul 2014 30 Sep 2014
Q2 2014 -51 -149 -1.5% 01 Apr 2014 30 Jun 2014
Q1 2014 -47 01 Jan 2014 31 Mar 2014
Q4 2013 -52 01 Oct 2013 31 Dec 2013
Q3 2013 -11 01 Jul 2013 30 Sep 2013
Q2 2013 97 01 Apr 2013 30 Jun 2013

Lipocine Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 0 +63 01 Jan 2024 31 Dec 2024
2023 -63 -36 -1.3% 01 Jan 2023 31 Dec 2023
2022 -27 -26 -16.1% 01 Jan 2022 31 Dec 2022
2021 -1 +168 +99% 01 Jan 2021 31 Dec 2021
2020 -169 -26 -17.9% 01 Jan 2020 31 Dec 2020
2019 -143 -54 -59.5% 01 Jan 2019 31 Dec 2019
2018 -90 +0 +0.38% 01 Jan 2018 31 Dec 2018
2017 -90 -28 -43.7% 01 Jan 2017 31 Dec 2017
2016 -62 -19 -41.8% 01 Jan 2016 31 Dec 2016
2015 -44 +18 +28.8% 01 Jan 2015 31 Dec 2015
2014 -62 -10 -18.2% 01 Jan 2014 31 Dec 2014
2013 -52 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.